ClinicalTrials.gg
Not yet recruitingNCT07905170Updated Oct 29, 2026

Spencer vs Positional Release Techniques for Chronic Subacromial Impingement

An interventional study of spencer technique and positional release technique in Chronic Subacromial Impingement Syndrome, sponsored by University of Management and Technology Lahore. Not yet recruiting at 1 site in Pakistan. Open to participants aged 35 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Oct 29, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
35 Years to 55 Years
Sex
All
01

Study summary

Chronic Subacromial Impingement Syndrome (SIS) is a common musculoskeletal condition characterized by shoulder pain, reduced range of motion, impaired proprioception, and functional disability. This randomized clinical trial aims to compare the effectiveness of the Spencer Technique and Positional Release Technique in reducing shoulder pain, improving proprioception and range of motion, and decreasing functional disability in patients with chronic subacromial impingement syndrome. A total of 32 participants will be randomly divided into two groups. Group A will receive the Spencer Technique, while Group B will receive the Positional Release Technique. The intervention will be conducted three times per week for six weeks, totaling 18 sessions. Outcomes will be assessed before and after the intervention using appropriate outcome measures for shoulder pain, proprioception, range of motion, and functional disability. Data will be analyzed using SPSS to compare the effectiveness of both interventions and determine which technique provides greater improvements in patients with chronic subacromial impingement syndrome.

02

Conditions studied

  • Chronic Subacromial Impingement Syndrome

Keywords

  • Spencer Technique
  • Positional Release Technique
  • Proprioception
  • Chronic Subacromial Impingement Syndrome
03

In context

Shoulder Impingement Syndrome

320 studies on the registry are indexed under Shoulder Impingement Syndrome; 62 are open to participants now.

This study's planned enrollment of 32 is below the median of 54 across 271 interventional studies indexed under Shoulder Impingement Syndrome.

Browse Shoulder Impingement Syndrome studies →

Lead sponsor

University of Management and Technology Lahore is the lead sponsor of 39 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adult individuals between 35 to 55 years old regardless of gender Chronic SAIS diagnosed clinically with symptom duration greater than three months.

Passive shoulder joint impingement test: Hawkins-Kennedy Test. An NPRS pain score range of 4-6. Limited glenohumeral range of motion.

Exclusion criteria

Exclusion Criteria:

Any recent history of surgery involving the shoulder joint. Any recent History of any shoulder fracture, glenohumeral dislocation, or frozen shoulder condition.

MRI or ultrasound confirmed full thickness rotator cuff tear. Individual's is suffering from cervical radiculopathy or brachial plexus involvement with upper extremity referral.

Individuals with systemic inflammatory joint disease (rheumatoid arthritis, ankylosing spondylitis).

Individuals with Diseases affecting upper limb proprioception (stroke, peripheral neuropathies).

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    spencer technique

    This group will receive spencer technique. 3 sessions per week for 6 weeks.

    Other: spencer technique

  • Active comparator
    positional release technique

    This group will receive positional release technique. 3 sessions per week for 6 weeks

    Other: positional release technique

Interventions

  • Otherspencer technique

    spencer technique. 3 sessions per week for 6 weeks

  • Otherpositional release technique

    positional release technique. 3 sessions per week for 6 weeks

06

What researchers measure

Primary outcomes

  1. Numerical Pain Rating Scale (NPRS)

    Pain severity will be assessed via the 11-point NPRS (0 = no pain; 10 = maximal pain imaginable) during resting and overhead activities. The NPRS has shown high reliability (ICC = 0.95-0.96) and validity in shoulder pathology.

    Time frame: Baseline and after 6 weeks

  2. Joint Position Sense (Proprioception)

    The shoulder joint proprioception will be tested with a Joint Position Sense (JPS) test. The test will be administered in flexed shoulder position (90°), abducted shoulder position (90°) and external rotation position (60°). The patient's arm will be passively positioned to achieve target position and hold it for several seconds for memorization; subsequently, the limb will return to the neutral starting position. Then the patient will be asked to reproduce the target position by moving the arm without vision assistance.

    Time frame: Baseline and after 6 weeks

  3. Shoulder Range of Motion - clinometer

    Glenohumeral joint active and passive range of motion, including flexion, abduction, internal rotation, and external rotation, will be assessed using a smartphone-based clinometer application. Smartphone clinometers have been reported as valid and reliable tools for measuring shoulder range of motion, demonstrating excellent intra-rater reliability when compared with the standard universal goniometer

    Time frame: Baseline and after 6 weeks

  4. Shoulder Pain and Disability Index (SPADI)

    The SPADI, a 13-question self-administered survey that includes a five-question subscale measuring pain and an eight-question subscale assessing disability, will be used to measure functional disability, rated on a scale of 0 to 10. The total score of SPADI (0-100) is obtained by taking the average of the scores of the two subscales, multiplied by 100. SPADI has been found to have excellent reliability (α = 0.86-0.96; ICC = 0.84-0.95).

    Time frame: Baseline and after 6 weeks

07

Study locations

1 site
  • UMT
    Lahore, Punjab Province 54000, Pakistan
    • Fizza Masood Dr., MS-OMPT · Contactfizza.masood@umt.edu.pk · +923344318731
    • Rabia Jawa CoD Physical Therapy and Rehabilitation, MPhil PT · Contactrabia.jawa@umt.edu.pk · +923434570838
    • Farah Roshan · Sub investigator
08

References and documents

Individual participant data

Plan to share: Yes — The results data collected , de-identified individual participant data will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: 6 months after the publication of the manuscript.

Access criteria: The data can be requested from the corresponding author.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07905170
Lead sponsor
University of Management and Technology Lahore
Responsible party
Fizza Masood (Assistant Professor, University of Management and Technology Lahore) — Principal investigator
First posted
Oct 29, 2026
Start date
Oct 23, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 29, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion